Navigation Links
Call for Nominations for the 2009 C.A.R.E. Pharmacy Award
Date:6/1/2009

Eisai Inc. and the Alzheimer's Association Support Award to Recognize Critical Role of Pharmacists in Alzheimer's Care

WOODCLIFF LAKE, N.J., June 1 /PRNewswire/ -- Eisai Inc., in coordination with the Alzheimer's Association, calls on individuals with Alzheimer's disease and their caregivers across America to nominate local pharmacists for the 2009 C.A.R.E. (Commitment to Alzheimer's. Recognition of Excellence.) Pharmacy Award. This award recognizes the vital role that pharmacists play in helping as many as 5.3 million Americans living with Alzheimer's disease and their 10 million caregivers.(1)

Now in its ninth year, the C.A.R.E. Pharmacy Award reflects Eisai's human health care (hhc) mission, which regards patients and their families as the most important participants in the health care process. The C.A.R.E. Pharmacy Award is one way for people with the disease and caregivers to acknowledge the extraordinary efforts of community pharmacists and their impact on the lives of people affected by Alzheimer's disease.

"Alzheimer's is a disease that affects both patients and their caregivers, and Eisai's commitment to the patient and caregiver communities is unwavering," said Cynthia Schwalm, President of Eisai Inc. "We recognize the integral role that community pharmacists play in each patient's treatment and care, providing ongoing monitoring, counseling and support. The C.A.R.E. Pharmacy Award allows us to acknowledge their efforts and showcase best practices in caregiving techniques. We are proud to be working with the Alzheimer's Association to honor the extraordinary contributions of pharmacists who are making a difference in the lives of people affected by Alzheimer's disease."

In addition to being recognized, the winning pharmacist's local Alzheimer's Association chapter will receive a $1,500 donation for its vital support programs. Another $1,500 donation will go to the Alzheimer's Association chapters located in the areas from which the most nominations are submitted.

"The Alzheimer's Association is excited to partner again with Eisai to recognize pharmacists who actively participate as part of the team of care providers for those with Alzheimer's disease," said Elizabeth Gould, MSW, director of quality care programs for the Alzheimer's Association. "We commend pharmacists who take the time to build relationships with their patients living with Alzheimer's and their caregivers, helping to educate them about Alzheimer's disease and enhancing the support they receive."

How to Nominate a Pharmacist

Alzheimer's patients and caregivers can nominate pharmacists through September 2009 by visiting www.carepharmacyaward.com. To be eligible, nominees must be licensed pharmacists involved in activities within the last year that have helped people with Alzheimer's disease, and these activities must have had a positive effect on patients and/or their families. A full description of the award and nomination criteria can be found at www.carepharmacyaward.com.

The winning pharmacist will be selected in October from the nominee pool by a panel of three judges. One judge is a director at the Alzheimer's Association's national office. The other two judges are past winners of this award. Each has spent more than 20 years improving the care of people with Alzheimer's disease through educational, advocacy and caregiver support programs.

About Eisai Inc.

Eisai Inc. is a U.S. pharmaceutical subsidiary of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: neurology, gastrointestinal disorders and oncology/critical care. Established in 1995 and ranked among the top-20 U.S. pharmaceutical companies (based on retail sales), Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly grown to become an integrated pharmaceutical business with fiscal year 2008 (year ended March 31, 2009) sales of approximately $3.7 billion, including the results of the acquisition of MGI PHARMA, INC.

Eisai Inc. employs approximately 1,900 people at its headquarters in Woodcliff Lake, NJ, at its state-of-the-art pharmaceutical production and formulation research and development facility in Research Triangle Park, NC, and in the field. For more information about Eisai, please visit www.eisai.com.

About the Alzheimer's Association

The Alzheimer's Association is the leading voluntary health organization in Alzheimer's research, care and support. Our mission is to eliminate Alzheimer's disease through the advancement of research, provide and enhance care and support for all affected, and reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. For more information, visit www.alz.org.

Reference: 1. Alzheimer's Association. Alzheimer's Disease Facts and Figures. 2009:10,65.


'/>"/>
SOURCE Eisai Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Prix Galien USA Now Accepting Nominations for Premiere Biopharmaceutical Industry Award
2. Deadline Extended for Nominations for Jay and Rose Phillips Awards and Phillips Caregiver Award
3. Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award
4. Courage Center Now Accepting Nominations for Jay and Rose Phillips Awards and Phillips Caregiver Award
5. 2009 Prix Galien USA Now Accepting Nominations for Top Prize in Biopharmaceutical Research and Development
6. Pennsylvania Governor Rendell Announces Nominations
7. Cherokee Inspired Comfort Awards Program Call for Nominations
8. GBC Seeks Nominations for Fourth Annual Bioscience Awards
9. 12th Annual 40-Under-Forty Achievement Awards Call For Nominations
10. Eisai Inc. and the North American Thrombosis Forum (NATF)* Introduce the DVTeamCare(TM) Hospital Award and Call for Nominations
11. Deadline Extended to Submit Nominations for Depression Awards Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... ... 2016, a powerful cellular therapy software application that helps blood and marrow transplant ... , Since Transtem’s initial launch, Mediware has continued to enhance core application features. ...
(Date:5/4/2016)... ... May 04, 2016 , ... International Conference on Obesity and ... 2016 at Las Vegas. It aims to bring together academicians, scientists, dietitians, surgeons, ... organizations across the globe; making the conference a perfect platform to share experience ...
(Date:5/3/2016)... ... May 04, 2016 , ... The National Association of Professional Women (NAPW) ... of the Year Circle. She is recognized with this prestigious distinction for leadership in ... than 850,000 members and over 200 operating Local Chapters. , “I’m pleased to welcome ...
(Date:5/3/2016)... ... , ... Sue Desmond-Hellmann, chief executive officer of the Bill & Melinda Gates ... possibility in her keynote address at Georgia State University’s spring commencement on ... rich experience as a scientist, physician and executive, Desmond-Hellmann leads the Gates Foundation’s efforts ...
(Date:5/3/2016)... Baltimore, Md. (PRWEB) , ... May 03, 2016 , ... ... devastating consequences of inappropriate or excessive levels of alcohol use. Alcohol and its ... fetal alcohol spectrum disorders to the susceptibility to strokes in those 65 years and ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... OSWEGO, Ore. , May 3, 2016 /PRNewswire/ ... endovascular medical technology, today announced Food and Drug ... cardiac resynchronization defibrillator that provides heart failure patients ... scans. Iperia devices also have remote monitoring with ... that adapts the heart rate in response to ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK ... of extending care beyond the implant at the Heart ... 4-7 in San Francisco . ... delivering the highest quality of patient care and satisfaction ... cared for each and every tomorrow," said Marlou ...
(Date:5/3/2016)... 2016 Pharmaceutical giant Johnson & ... a woman who says its talc-based powder products caused ... Ristesund $5 million in compensatory damages and $50 ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , This is the ... In February, the same court awarded $72 million to ...
Breaking Medicine Technology: